Clinical Trial Update: Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating branched-chain amino acid supplementation in patients with liver cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Branched Chain Amino Acid Supplement (branched-chain amino acids)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Liver Cirrhosis | Phase 4 | Status: COMPLETED